Glaxosmithkline Pharmaceuticals consolidated net profit rises 9.45% in the December 2022 quarter

Sales decline 1.67% to Rs 802.30 crore

Net profit of Glaxosmithkline Pharmaceuticals rose 9.45% to Rs 164.56 crore in the quarter ended December 2022 as against Rs 150.35 crore during the previous quarter ended December 2021. Sales declined 1.67% to Rs 802.30 crore in the quarter ended December 2022 as against Rs 815.92 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales802.30815.92 -2 OPM %28.5124.24 -PBDT252.03207.55 21 PBT235.62189.68 24 NP164.56150.35 9

Powered by Capital Market - Live News